Hollis Eden News
Most Popular Hollis Eden Story
Emerging Drug Developer: Hollis-Eden
When Richard Hollis got up on March 7, he was the CEO of a company that was primarily known for its work advancing Neumune, a therapy for acute radiation syndrome and a prime candidate for... Read more...
Latest Headlines
- September 7, 2007
- August 31, 2007
- August 30, 2007
Paid Research Reports
- RNA therapy: the next big thing after monoclonal antibodies?
- Biotech M&A Strategies: Deal assessments, trends and future prospects
- The Dermatology Market Outlook to 2013: Competitive landscape, pipeline analysis and growth opportunities
- Pipeline Insight: Cancer Overview - Breast, Gynecological, Genitourinary - Diverse drugs approaching the market for many tumor t
- Sales Force Effectiveness
